What is a tangible step we can take to reduce #medicineshortages🤔? ✅Require marketing authorisation holders by EU🇪🇺law to maintain a safety stock of 2-4 months for medicines of major therapeutic interest. Click to learn more! #FilltheGap accesstomedicine.eu/solving-the-pr…

Official national databases show that manufacturing issues remain a major cause for #MedicineShortages - GIRP-European Healthcare Distribution Association also calls for harmonisation of criteria for root causes of shortages among Member States? * Information from 12 Member States providing data publicly.

We take the opportunity of #WordStatisticsDay 📈to present some interesting figures from our study "Savings from #ParallelImports in Europe 🇪🇺". 👉Read more at bit.ly/3dBg4DS

When crisis struck this year, parallel distributors sprang into action to deliver Europeans🇪🇺the medicines💊they needed to stay alive. Watch this video👇to hear from parallel distributors across the continent on what they did to #FillTheGap! accesstomedicine.eu

PGEU Yes, #MedicineShortage immediately affects patients. In some cases, it can take months for doctors to get to the right doses of different💊, which is time enough for their symptoms to return. #ParallelDistribution enables them to avoid the adaptation process to different 💊.

Today is #InternationalWomensDay ♀️! At EurimPharm GmbH, one of Affordable Medicines Europe's members, women's 👩 ratio accross all qualifications is 8⃣0⃣%. According to Friederike Hrubesch-Mohringer, CEO of EurimPharm, women are the main pillars of our healthcare system 👏.

In Bulgaria 🇧🇬 there is a shortage of #Nolvadex, used to prevent and treat #breastcancer 🦀. During the last 8⃣ months, parallel importers have stepped in to #FillTheGap with parallel imported Nolvadex, to help Bulgarian women 👩 in their fight.

Freier Warenverkehr, Wirtschaftlichkeit und Bezahlbarkeit durch Wettbewerb, Vor-Ort-Apotheken stärken und Digitalisierung in Patientennutzen umsetzen. 👉 Fünf Punkte für die Gesundheitspolitik der kommenden Wahlperiode. ow.ly/2eQo50FWiPA

Medicines shipment 💊 from Germany to Ukraine has started. Thanks to our 🇩🇪 German member that donated another 3 pallets of medicines to support the Ukrainian people 🇺🇦 during this unprecedented time! This is European solidarity in action 🇪🇺. #WeStandWithUkraine

Pictures say a lot - trucks 🚚 of donated medicines coming from members left from logistics centre of Prague to Ukraine 🇺🇦. We could not be prouder of the generosity of our members who are on the side of the Ukrainian people 💪. #WeStandWithUkraine 🕊️

This week, our members shipped two more trucks 🚚🚚 to Ukraine. In total, they delivered another 4️⃣7️⃣ pallets of donated medicines for Ukrainian people 💊. 🕊️ #WeStandWithUkraine️ 🇺🇦

Can strategic autonomy lead to a more secure EU 🇪🇺 #pharmaceutical supply? This is the important question Kasper Ernest, secretary general of Affordable Medicines Europe, discusses in his latest article 📰. Read below about this topic 👉 kont.ly/af55220c

Kick-off of the Affordable Medicines Europe General Assembly in #WonderfulCopenhagen by President Jörg Geller. Looking forward to great input and discussions on market developments, political outlook and much more!

While welcoming the new EU Pharma Strategy, Dorte Bech Vizard highlighted the importance of #affordability and emphasized how #paralleldistribution "enables competition in a business where monopoly otherwise prevails".

Based on IQVIA report on #shortages published in 2020, Shabnam Hanassab stressed that "the type of products where shortages happen are not actually products that have been traded, but mostly generic products".

In his opening speech, @LMST_LBNielsen noted that availability and affordability are two of the main challenges for healthcare, and stressed the important role played by #paralleldistribution in ensuring safe and #affordablemedicines in Europe 🇪🇺.

During our General Assembly in Copenhagen, we had the pleasure to welcome Monika Derecque-Pois in our panel about the #futureofpharma.

During our General Assembly in Copenhagen, we had the pleasure to welcome Olga Solomon in our panel about the #futureofpharma.

During our General Assembly in Copenhagen, we had the pleasure to welcome @LMST_LBNielsen from the Danish Medicines Agency DK Medicines Agency who shared interesting insights with us about the #futureofpharma.

400 Mio. Euro durch Importarzneimittel eingespart Krankenkassen profitieren für das Gesamtjahr 2022 von 400 Mio. Euro an direkten Einsparungen durch Preisunterschiede zwischen dem Original und dem günstigeren importierten Original. ow.ly/2gpE50MJ4Ur